Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Two Formulations of GSK Biologicals' Varicella Vaccine

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: December 5, 2007
Last updated: November 21, 2012
Last verified: November 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2008
  Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: September 3, 2009